🇺🇸 FDA
Patent

US 10005743

Methods for producing viloxazine salts and novel polymorphs thereof

granted A61PA61P13/00A61P25/00

Quick answer

US patent 10005743 (Methods for producing viloxazine salts and novel polymorphs thereof) held by Supernus Pharmaceuticals, Inc. expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P13/00, A61P25/00, A61P25/20, A61P25/24